Trial of the Histone-Deacetylase Inhibitor ITF2357 Followed by Mechlorethamine in Relapsed/Refractory Hodgkin's Lymphoma

Clinical trial NCT00792467 · COMPLETED

Trial details

NCT number: NCT00792467
Sponsor: Italfarmaco
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hodgkin's Lymphoma

Start date: 2008-02-01
Primary completion: 2010-07-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.